Evidence map›Paper›PMID 31551330›Full record

ArticlemBio2019

Resistance Evolution against Phage Combinations Depends on the Timing and Order of Exposure.

Rosanna C T Wright, Ville-Petri Friman, Margaret C M Smith, Michael A Brockhurst

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Antimicrobial agents and chemotherapy · 2026
    Article
  9. Review
  10. Article
  11. Antibiotics (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Phage Therapy forAntibiotics (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail againstPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rosanna C T WrightDepartment of Biology, University of York, York, United Kingdom r.c.wright@sheffield.ac.uk.ORCID 0000-0002-8095-8256
Ville-Petri FrimanDepartment of Biology, University of York, York, United Kingdom.
Margaret C M SmithDepartment of Biology, University of York, York, United Kingdom.ORCID 0000-0002-4150-0496
Michael A BrockhurstDepartment of Animal and Plant Sciences, University of Sheffield, Sheffield, United Kingdom.
University of York · GBUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phage therapy is a promising alternative to chemotherapeutic antibiotics for the treatment of bacterial infections. However, despite recent clinical uses of combinations of phages to treat multidrug-resistant infections, a mechanistic understanding of how bacteria evolve resistance against multiple phages is lacking, limiting our ability to deploy phage combinations optimally. Here, we show, using

Indexed as

Drug Resistance, MultipleHost-Pathogen InteractionsHumansPhage TherapyPseudomonas InfectionsPseudomonas Phagesbacteriophagesbacteriophage therapyevolutionary biologyPseudomonas aeruginosaresistance evolution

Identifiers

PMID31551330
PMCPMC6759759
OpenAlexW2975499037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.